A Prospective, Multicenter, Observational Study of the Efficacy and Safety of Corticosteroids for Tumor-Induced Central and Peripheral Neuropathic Pain in Cancer Patients. - A Prospective Observational Study of the Efficacy and Safety of Corticosteroids for Tumor-Induced Neuropathic Pain.

Tohoku University Graduate School of Medicine0 个研究点目标入组 200 人开始时间: 2020年6月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Patients whose physicians consider it inappropriate to participate in the research. Patients who are pregnant, lactating, or may be pregnant. Patients with diabetes who have poor glycemic control who need additional insulin injections Patients with an infection-caused fever of 38 degrees or higher Patients undergoing treatment for an active gastrointestinal ulcer Patients with diagnoses of hematological malignancy Serious adverse events due to corticosteroid in the past Patients who started a new anticancer treatment with a molecularly targeted agency or immune checkpoint inhibitor within 2 weeks, or are scheduled to start the treatment within 1 week Patients were administrated corticosteroids more than the scheduled dose on the day before the start of treatment Patients scheduled to administrate corticosteroids more than its regular doses in one week for the treatment of adverse effects by anticancer therapy Patients who are scheduled to receive surgery for the pain control in a week

发起方

Tohoku University Graduate School of Medicine